v3.23.1
STOCKHOLDERS’ DEFICIT (Details Narrative) - $ / shares
9 Months Ended 12 Months Ended
Jan. 31, 2023
Apr. 30, 2022
May 02, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Preferred Stock, Shares Authorized 100 100 100
Preferred Stock, Shares Outstanding 51 51  
Warrant [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number 2,143,167 1,255,667  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 0.17 $ 0.25  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms 2 years 3 months 4 years 8 months 12 days  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value $ 0.11 $ 0.11  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period 887,500    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 0.06